U.S., June 26 -- ClinicalTrials.gov registry received information related to the study (NCT07035938) titled 'T-cell Developmental Status in Patients With Malignant Hematological Tumors' on June 16.
Brief Summary: To evaluate the immune status and prognosis of patients with malignant hematological tumors, thereby guiding clinical therapeutic strategies.
Study Start Date: June 22
Study Type: OBSERVATIONAL
Condition:
Hematologic Malignancy
Intervention:
OTHER: observational study
observational study
Recruitment Status: RECRUITING
Sponsor: The First Affiliated Hospital of Xiamen University
Information provided by (Responsible Party): Zhijuan Lin, The First Affiliated Hospital of Xiamen University
Disclaimer: Curated by HT Syndicatio...